Related references
Note: Only part of the references are listed.CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation
Julia Kuhlmann et al.
CLINICA CHIMICA ACTA (2017)
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
Sebastian Palmqvist et al.
BRAIN (2016)
Accelerating rates of cognitive decline and imaging markers associated with -amyloid pathology
Philip S. Insel et al.
NEUROLOGY (2016)
The transitional association between β-amyloid pathology and regional brain atrophy
Philip S. Insel et al.
ALZHEIMERS & DEMENTIA (2015)
Amyloid biomarkers in Alzheimer's disease
Kai Blennow et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Predicting Reduction of Cerebrospinal Fluid β-Amyloid 42 in Cognitively Healthy Controls
Niklas Mattsson et al.
JAMA NEUROLOGY (2015)
Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease
Niklas Mattsson et al.
BRAIN (2015)
Emerging β-Amyloid Pathology and Accelerated Cortical Atrophy
Niklas Mattsson et al.
JAMA NEUROLOGY (2014)
Apolipoprotein E Genotype and the Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers for Alzheimer Disease
Ronald Lautner et al.
JAMA PSYCHIATRY (2014)
ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions
Philip B. Verghese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
Joseph M. Castellano et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
APOE Predicts Amyloid-Beta but Not Tau Alzheimer Pathology in Cognitively Normal Aging
John C. Morris et al.
ANNALS OF NEUROLOGY (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Longitudinal Modeling of Age-Related Memory Decline and the APOE ε4 Effect
Richard J. Caselli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Simultaneous measurement of β-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology
A Olsson et al.
CLINICAL CHEMISTRY (2005)
APOE ε4 allele is associated with reduced cerebrospinal fluid levels of Aβ42
JA Prince et al.
NEUROLOGY (2004)
Cerebrospinal fluid β-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease:: The effect of APOE ε4 allele
T Sunderland et al.
BIOLOGICAL PSYCHIATRY (2004)
Share Paper
